74%
of retail accounts lose money when trading CFDs with this provider.
Investments involve risks and are not suitable for all investors. CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage.
74%
of retail investor accounts lose money when trading CFDs with this provider.
You should consider whether you understand how CFDs work, and whether you can afford to take the high risk of losing your money.
74%
of retail accounts lose money when trading CFDs with this provider.
Investments involve risks and are not suitable for all investors. CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage.
74%
of retail investor accounts lose money when trading CFDs with this provider.
You should consider whether you understand how CFDs work, and whether you can afford to take the high risk of losing your money.
English (International)
Danaher Corp
Closed
Sector Healthcare
207.9 1.33
Overview
Share price change
24h
Min
207.01
Max
209.35
Income | 268M 1.1B |
|---|---|
Sales | 738M 6.5B |
P/E Sector Avg | 38.749 73.394 |
EPS | 2.14 |
Dividend yield | 0.53 |
Profit margin | 16.606 |
Employees | 63,000 |
EBITDA | -230M 1.4B |
Recommendations | Buy |
|---|---|
12 Months Forecast | +26.89 upside |
Dividend yield Sector Avg | 0.53% 3.09% |
|---|---|
Next Dividend date | 25 Apr 2025 |
Next Ex Dividend date | 28 Mar 2025 |
Market Cap | -15B 147B |
|---|---|
Previous open | 206.57 |
Previous close | 207.9 |
News Sentiment
By Acuity
27%
73%
75 / 393 Healthcare
Technical Score
By Trading Central
Confidence
Weak Bullish Evidence
Danaher Corp Chart
Past performance is not a reliable indicator of future results.
Related News
Peer Comparison
Price change
Danaher Corp Forecast
Price Target
By TipRanks
26.89% upside
12 Months Forecast
Average 263.87 USD 26.89%
High 300 USD
Low 240 USD
Based on 18 Wall Street analysts offering 12 month price targets forDanaher Corp - Dist in the last 3 months.
Sentiment
By Acuity
75 / 393 Healthcare
News Sentiment
Bullish Evidence
Volatility
Below average
News Volume (RCV)
Above average
Financials
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$
About Danaher Corp
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automation, centrifugation, liquid handling automation instruments, antibodies and reagents, and particle counting and characterization; microscopes; protein consumables; industrial filtration products; and genomic medicines, such as custom nucleic acid products, plasmid DNA, RNA, and proteins under the ABCAM, ALDEVRON, BECKMAN COULTER, IDT, LEICA MICROSYSTEMS, MOLECULAR DEVICES, PALL, PHENOMENEX and SCIEX brands. The Diagnostics segment offers chemistry, immunoassay, microbiology, and automation systems; and molecular, acute care, and pathology diagnostics products. This segment also provides clinical instruments, reagents, consumables, software, and services for hospitals, physicians' offices, reference laboratories, and other critical care settings. The company has a research collaboration with Stanford University's Department of Bioengineering for cancer drug development. The company was formerly known as Diversified Mortgage Investors, Inc. and changed its name to Danaher Corporation in 1984. Danaher Corporation was founded in 1969 and is based in Washington, the District of Columbia.
